Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat

Life Sciences

Volumn 75, Issue 10, 2004, Pages 1243-1253

  Loots, Du Toit ^a   Mienie, Lodewyk J ^a   Bergh, Jacobus J ^a   Van Der Schyf, Cornelis J ^a,b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Acetyl L carnitine; ALCAR; Hydroxyl Radical; MPP+; MPTP; Rat; Xanthine Oxidase

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CARNITINE ACETYLTRANSFERASE; CATION; DRUG METABOLITE; HYDROXYL RADICAL; LEVACECARNINE; SALICYLIC ACID; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; MALE; MEASUREMENT; NONHUMAN; OXIDATIVE STRESS; PROTEIN TRANSPORT; RAT; URINALYSIS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ACETYLCARNITINE; ANIMALS; BIOLOGICAL MARKERS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROXYL RADICAL; MALE; MPTP POISONING; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; URIC ACID;

PARKINSONIA;

EID: 3042543908     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.03.007     Document Type: Article

References (49)

1. + induced oxygen radical formation with mitochondrial enzymes. Free Radic. Biol. Med. 15(2):1993;181-186
2. + toxicity in rat striatal slices: relationship between non-selective effects and free radical production. Neurochem. Res. 21(1):1996;73-78
3. Bacsik C.J., Swift J.Q., Hargreaves K.M. Toxic systemic reactions of bupivacaine and etidocaine. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 79(1):1995;18-23
4. Bodis-Wollner I., Chung E., Ghilardi M.F., Glover A., Onofrj M., Pasik P., Samson Y. Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. J. Neural. Transm. Park. Dis. Dement. Sect. 3(1):1991;63-72
5. Boerrigter M.E., Franceschi C., Arrigoni-Martelli E., Wei J.Y., Vijg J. The effect of L-carnitine and acetyl-L-carnitine on the disappearance of DNA single-strand breaks in human peripheral blood lymphocytes. Carcinogenesis. 14(10):1993;2131-2136
6. Chiba K., Trevor A., Castagnoli N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120(2):1984;574-578
7. Chiueh C.C., Wu R.M., Mohanakumar K.P., Sternberger L.M., Krishna G., Obata T., Murphy D.L. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. N. Y. Acad. Sci. 738:1994;25-36
8. Cleeter M.W., Cooper J.M., Schapira A.H. Irreversible inhibition of mitochondrial Complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58(2):1992;786-789
9. Davey G.P., Tipton K.F., Murphy M.P. Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode. Biochem. J. 288(Pt 2):1992;439-443
10. + uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity. Br. J. Pharmacol. 109(2):1993;411-414
11. Di Giacomo C., Latteri F., Fichera C., Sorrenti V., Campisi A., Castorina C., Russo A., Pinturo R., Vanella A. Effect of acetyl-L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem. Res. 18(11):1993;1157-1162
12. +) cause rapid ATP depletion in isolated hepatocytes. Biochem. Biophys. Res. Commun. 137(1):1986;310-315
13. Friedrich A., Prasad P.D., Freyer D., Ganapathy V., Brust P. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier. Brain Res. 968(1):2003;69-79
14. Ganapathy M.E., Huang W., Rajan D.P., Carter A.L., Sugawara M., Iseki K., Leibach F.H., Ganapathy V. β-Lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J. Biol. Chem. 275(3):2000;1699-1707
15. Gluck M.R., Krueger M.J., Ramsay R.R., Sablin S.O., Singer T.P., Nicklas W.J. Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations. J. Biol. Chem. 269(5):1994;3167-3174
16. Goldstein R.S., Smith P.F., Tarloff J.B., Contardi L., Rush G.F., Hook J.B. Biochemical mechanisms of cephaloridine nephrotoxicity. Life Sci. 42(19):1988;1809-1816
17. Grootveld M., Halliwell B. 2, 3-Dihydroxybenzoic acid is a product of human aspirin metabolism. Biochem. Pharmacol. 37(2):1988;271-280
18. Harik S.I., Hritz M.A. Effect of acetyl-L-carnitine on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity. Biochem. Pharmacol. 45(10):1993;2170-2172
19. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U. S. A. 82(7):1985;2173-2177
20. + by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur. J. Pharmacol. 106(2):1984;455-456
21. Kaur J., Sharma D., Singh R. Acetyl-L-carnitine enhances Na(+), K(+)-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci. Lett. 301(1):2001;1-4
22. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J., Nikaido H., Hashimoto N., Asano M., Tsuji A. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J. Neurochem. 79(5):2001;959-969
23. +: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase. Free Radic. Biol. Med. 15(2):1993;169-179
24. Klaunig J., Xu Y., Han C., Kamendulis L., Chen J., Heiser C., Gordon M., Mohler E. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc. Soc. Exp. Biol. Med. 220:1999;249-254
25. Kristufek D., Rudorfer W., Pifl C., Huck S. Organic cation transporter mRNA and function in the rat superior cervical ganglion. J. Physiol. 543(Pt 1):2002;117-134
26. Kuhn W., Muller T., Büttner T., Gerlach M. Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia. Stroke. 26(10):1995;1959-1960
27. Lahjouji K., Mitchell G.A., Qureshi I.A. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol. Genet. Metab. 73(4):2001;287-297
28. Langston J.W., Forno L.S., Rebert C.S., Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292(2):1984;390-394
29. Langston J.W., Langston E.B., Irwin I. MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurol. Scand. 100:1984;49-54. (Suppl.)
30. Luo X., Lehotay D.C. Determination of hydroxyl radicals using salicylate as a trapping agent by gas chromatography-mass spectrometry. Clin. Biochem. 30(1):1997;41-46
31. Mazzio E., Yoon K.J., Soliman K.F. Acetyl-L-carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells. Biochem. Pharmacol. 66(2):2003;297-306
32. McKay D.L., Blumberg J.B. The role of tea in human health: an update. J. Am. Coll. Nutr. 21(1):2002;1-13
33. Miele M., Esposito G., Migheli R., Sircana S., Zangani D., Fresu G.L., Desole M.S. Effects of allopurinol on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurochemical changes in the striatum and in the brainstem of the rat. Neurosci. Lett. 183(3):1995;155-159
34. Montgomery J., Ste-Marie L., Boismenu D., Vachon L. Hydroxylation of aromatic compounds as indices of hydroxyl radical production: a cautionary note revisited. Free Radic. Biol. Med. 19(6):1995;927-933
35. Obata T. Dopamine efflux by MPTP and hydroxyl radical generation. J. Neural. Transm. 109(9):2002;1159-1180
36. Paradies G., Ruggiero F.M., Petrosillo G., Gadaleta M.N., Quagliariello E. Carnitine-acylcarnitine translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-L-carnitine. Mech. Ageing Dev. 84(2):1995;103-112
37. Pettegrew J.W., Levine J., McClure R.J. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiatry. 5(6):2000;616-632
38. Pitts S.M., Markey S.P., Murphy D.L., Weisz A. Recommended practices for the safe handling of MPTP. Markey S.P., Castagnoli N. Jr., Trevor A.J., Kopin I.J. MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. 1986;703-716 Academic Press, New York
39. Sablin S.O., Krueger M.J., Yankovskaya V.L., Tkachenko S.E., Razdolsky A.N., Bachurin S.O, Ramsay R.R., Singer T.P. Inhibition of NADH oxidation by 1-methyl-4-phenylpyridinium analogs as the basis for the prediction of the inhibitory potency of novel compounds. J. Biochem. Toxicol. 11(1):1996;33-43
40. Salach J.I., Singer T.P., Castagnoli N. Jr., Trevor A. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Biochem. Biophys. Res. Commun. 125(2):1984;831-835
41. Schinetti M.L., Rossini D., Greco R., Bertelli A. Protective action of acetylcarnitine on NADPH-induced lipid peroxidation of cardiac microsomes. Drugs Exp. Clin. Res. 13(8):1987;509-515
42. Schmidle C.J., Mansfield R.C. The aminomethylation of olefins. IV. The formation of 1-alkyl-4-aryl-1, 2, 3, 6-tetrahydropyridines. J. Am. Chem. Soc. 78:1956;425-428
43. +): reductive activation by NADPH cytochrome P-450 reductase. Biochem. Biophys. Res. Commun. 135(2):1986;583-588
44. Steffen V., Santiago M., de la Cruz C.P., Revilla E., Machado A., Cano J. Effect of intraventricular injection of 1-methyl-4-phenylpyridinium: protection by acetyl-L-carnitine. Hum. Exp. Toxicol. 14(11):1995;865-871
45. Tesco G., Latorraca S., Piersante P., Piacentini S., Amaucci L., Sorbi S. Protection from Oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine. Dementia. 3:1992;58-60
46. Tolwani R.J., Jakowec M.W., Petzinger G.M., Green S., Waggie K. Experimental models of Parkinson's disease: insights from many models. Lab. Anim. Sci. 49(4):1999;363-371
47. Virmani M.A., Caso V., Spadoni A., Rossi S., Russo F., Gaetani F. The action of acetyl-L-carnitine on the neurotoxicity evoked by amyloid fragments and peroxide on primary rat cortical neurones. Ann. N. Y. Acad. Sci. 939:2001;162-178
48. Weinberg G.L., Palmer J.W., VadeBoncouer T.R., Zuechner M.B., Edelman G., Hoppel C.L. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology. 92(2):2000;523-528
49. Winterbourn C.C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82-83:1995;969-974